Follow
Joyce A. Goldstein
Joyce A. Goldstein
NIEHS
Verified email at niehs.nih.gov
Title
Cited by
Cited by
Year
The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans.
SM De Morais, GR Wilkinson, J Blaisdell, K Nakamura, UA Meyer, ...
Journal of Biological Chemistry 269 (22), 15419-15422, 1994
13271994
Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese.
SM De Morais, GR Wilkinson, J Blaisdell, UA Meyer, K Nakamura, ...
Molecular pharmacology 46 (4), 594-598, 1994
10221994
Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data
CR Lee, JA Goldstein, JA Pieper
Pharmacogenetics and genomics 12 (3), 251-263, 2002
9082002
Clinical relevance of genetic polymorphisms in the human CYP2C subfamily
JA Goldstein
British journal of clinical pharmacology 52 (4), 349-355, 2001
8692001
The role of the CFP2C9-Leu 359 allelic variant in the tolbutamide polymorphism
TH Sullivan-Klose, BI Ghanayem, DA Bell, ZY Zhang, LS Kaminsky, ...
Pharmacogenetics and Genomics 6 (4), 341-349, 1996
8201996
Biochemistry and molecular biology of the human CYP2C subfamily
JA Goldstein, SMF de Morais
Pharmacogenetics and Genomics 4 (6), 285-300, 1994
7151994
Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid
D Dai, DC Zeldin, JA Blaisdell, B Chanas, SJ Coulter, BI Ghanayem, ...
Pharmacogenetics and Genomics 11 (7), 597-607, 2001
6092001
Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos
D Dai, J Tang, R Rose, E Hodgson, RJ Bienstock, HW Mohrenweiser, ...
Journal of Pharmacology and Experimental Therapeutics 299 (3), 825-831, 2001
4732001
Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans
JA Goldstein, MB Faletto, M Romkes-Sparks, T Sullivan, S Kitareewan, ...
Biochemistry 33 (7), 1743-1752, 1994
4571994
Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations
JA Goldstein, T Ishizaki, K Chiba, SMF de Morais, D Bell, PM Krahn, ...
Pharmacogenetics and Genomics 7 (1), 59-64, 1997
4211997
Halogenated biphenyls, terphenyls, naphthalenes, dibenzodioxins and related products
RD Kimbrough, AA Jensen
Elsevier, 2012
3962012
Kidney function influences warfarin responsiveness and hemorrhagic complications
NA Limdi, TM Beasley, MF Baird, JA Goldstein, G McGwin, DK Arnett, ...
Journal of the American Society of Nephrology 20 (4), 912-921, 2009
3832009
Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily
M Romkes, MB Faletto, JA Blaisdell, JL Raucy, JA Goldstein
Biochemistry 30 (13), 3247-3255, 1991
3551991
Identification of a null allele of CYP2C9 in an African–American exhibiting toxicity to phenytoin
RS Kidd, TB Curry, S Gallagher, T Edeki, J Blaisdell, JA Goldstein
Pharmacogenetics and Genomics 11 (9), 803-808, 2001
3462001
Separation of pure polychlorinated biphenyl isomers into two types of inducers on the basis of induction of cytochrome P-450 or P-448
JA Goldstein, P Hickman, H Bergman, JD Mckinney, MP Walker
Chemico-Biological Interactions 17 (1), 69-87, 1977
3031977
Influence of CYP2C9 and VKORC1 1173C/T Genotype on the Risk of Hemorrhagic Complications in African‐American and European‐American Patients on …
NA Limdi, G McGwin, JA Goldstein, TM Beasley, DK Arnett, BK Adler, ...
Clinical Pharmacology & Therapeutics 83 (2), 312-321, 2008
3012008
Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes
J Tang, Y Cao, RL Rose, AA Brimfield, D Dai, JA Goldstein, E Hodgson
Drug metabolism and disposition 29 (9), 1201-1204, 2001
2962001
Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor
Y Chen, SS Ferguson, M Negishi, JA Goldstein
Journal of Pharmacology and Experimental Therapeutics 308 (2), 495-501, 2004
2782004
A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin
RJ Ferguson, SMF De Morais, S Benhamou, C Bouchardy, J Blaisdell, ...
Journal of Pharmacology and Experimental Therapeutics 284 (1), 356-361, 1998
2781998
Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs
TS Klose, JA Blaisdell, JA Goldstein
Journal of biochemical and molecular toxicology 13 (6), 289-295, 1999
2681999
The system can't perform the operation now. Try again later.
Articles 1–20